全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量

Epidemiology, Clinical Features and Risk Factors for Imported Severe Malaria: Ten Years of Experience in a European Infectious Diseases Center

DOI: 10.4236/oalib.1114619, PP. 1-17

Subject Areas: Infectious Diseases

Keywords: Severe Malaria, Epidemiology, Symptoms, Risk Factors, Plasmodium spp

Full-Text   Cite this paper   Add to My Lib

Abstract

Background: Imported malaria remains a relevant clinical problem in Europe due to the rapid potential progression to severe and life-threatening disease, especially in non-immune patients and in the context in which diagnosis might be delayed due to lack of awareness of clinicians. In Portugal, malaria is a mandatory notifiable disease. In 2021 there were 79 cases reported to the Public Health System, but it is believed that cases are under-reported. Materials and Methods: In this retrospective observational study we analysed the medical records of 163 patients with Plasmodium spp infection, admitted in the infectious disease ward between March 2013 and March 2023. We analysed epidemiology, clinical features and risk factors for imported severe malaria. Results: Being male (p value: 0.028), older age (p value: 0.013), underlying chronic medical conditions (p value 0,005) and alcohol overuse (p value: 0.017) were identified as risk factors for severe malaria. Finding jaundice at presentation is also associated with severe disease (p value: < 0.001), as well as polypnea (p value: 0.016), postural hypotension (p value: 0.005), impaired consciousness (p value: 0.015) and prostration (p value: < 0.001). Blood test findings associated with severe malaria were the presence of anemia (p value < 0.001); elevation of transaminases (p value < 0.001); elevation of serum bilirubin (p value < 0.001); acute kidney injury (p value < 0.001) and leukocytosis (p value: 0.016). Discussion and conclusion: Primary and secondary prevention measures, such as pre-travel consultations, chemoprophylaxis, and early diagnosis and treatment, should be emphasized and improved among high-risk prospective travelers to malaria endemic countries. This finding should prompt clinicians to advise men, older travelers and travelers with underlying chronic medical conditions on malaria prevention, and highlights the need for early diagnosis and treatment for patients with early symptoms of malaria.

Cite this paper

Gonç, N. C. , alves, Gonç, Cristóvã, A. , o, Almeida, V. , Joã, Caria, O. , Carlos, M. , Magalhã, S. , es, Valadas, R. , Guerreiro, M. , Neto, S. , Cerqueira, B. , Ramirez, F. , Manata, M. J. and Maltez, F. (2026). Epidemiology, Clinical Features and Risk Factors for Imported Severe Malaria: Ten Years of Experience in a European Infectious Diseases Center. Open Access Library Journal, 13, e14619. doi: http://dx.doi.org/10.4236/oalib.1114619.

References

[1]  World Health Organization (2022) WHO Guidelines for Malaria 2022. https://www.who.int/publications/i/item/guidelines-for-malaria
[2]  World Health Organization (2022) World Malaria Report 2022. https://www.who.int/teams/global-malaria-programme/reports/world-malaria-report-2022
[3]  Wilson, M.E., Weld, L.H., Boggild, A., Keystone, J.S., Kain, K.C., von Sonnenburg, F., et al. (2007) Fever in Returned Travelers: Results from the GeoSentinel Surveillance Network. Clinical Infectious Diseases, 44, 1560-1568. https://doi.org/10.1086/518173
[4]  ECDC (2023) Malaria Annual Epidemiological Report for 2021 Key Facts. https://www.ecdc.europa.eu/sites/default/files/documents/malaria-annual-epidemiological-report-2021.pdf ecdc.europa.eu
[5]  World Health Organization (2023) WHO Guidelines for Malaria. https://www.who.int/publications/i/item/guidelines-for-malaria
[6]  Kama-liddin, C., Salnot, V., Leduc, M., Ezinmegnon, S., Broussard, C., Fievet, N., et al. (2017) PFI1785w: A Highly Conserved Protein Associated with Pregnancy As-sociated Malaria. PLOS ONE, 12, e0187817. https://doi.org/10.1371/journal.pone.0187817
[7]  Centers for Disease Control and Prevention (2020) Malaria Diagnostic Tests. https://www.cdc.gov/malaria/diagnosis_treatment/diagnosis.html
[8]  Khuu, D., Eberhard, M.L., Bristow, B.N., Javanbakht, M., Ash, L.R., Shafir, S.C., et al. (2018) Risk Factors for Severe Malaria among Hospitalized Patients in the United States, 2000-2014. Infection, Disease & Health, 23, 93-106. https://doi.org/10.1016/j.idh.2018.01.002
[9]  Xia, J., Wu, D.N., Wu, K., Zhu, H., et al. (2020) Epidemiology of Plasmodium falciparum Malaria and Risk Fac-tors for Severe Disease in Hubei Province, China. American Journal of Tropical Medicine and Hygiene, 103, 1534-1539.
[10]  Ndefo, J.C., Okagu, I.U., Agbowo, C.O., et al. (2021) Alcohol Overuse Increases Susceptibility to Malaria and Its Complications: A Pilot Study. Nigerian Journal of Parasitology, 42, 194-205.
[11]  Wyss, K., Wångdahl, A., Vesterlund, M., et al. (2017) Obesity and Diabetes as Risk Factors for Severe Plasmodium falciparum Malaria: Results from a Swedish Nationwide Study. Clinical Infectious Diseases, 65, 949-958. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5848256/
[12]  Anastasia, P., Paul, B., Sebastian, S., Stanton, N. and Geoffrey, P. (2009) Risk Factors for Severe Disease in Adults with Falciparum Malaria. OUP Academic.
[13]  Kee-gan, L.T. and Dushoff, J. (2013) Population-Level Effects of Clinical Immunity to Malaria. BMC Infectious Diseases, 13, Article No. 428.
[14]  Gupta, S., Snow, R.W., Donnelly, C.A., Marsh, K. and Newbold, C. (1999) Immunity to Non-Cerebral Severe Malaria Is Acquired after One or Two Infections. Nature Medicine, 5, 340-343. https://doi.org/10.1038/6560
[15]  Gatton, M.L. and Cheng, Q. (2004) Modeling the Development of Acquired Clinical Immunity to Plasmodium falciparum Malaria. Infection and Immunity, 72, 6538-6545. https://doi.org/10.1128/iai.72.11.6538-6545.2004
[16]  European Centre for Disease Prevention and Control (2014) Assessing the Burden of Key Infec-tious Diseases Affecting Migrant Populations in the EU/EEA. ECDC. https://www.ecdc.europa.eu/en/publications-data/assessing-burden-key-infectious-diseases-affecting-migrant-populations-eueea
[17]  Kurth, F., Develoux, M., Mechain, M., Malvy, D., et al. (2017) Severe Malaria in Europe: An 8-Year Multi-Centre Observational Study. Malaria Journal, 16, Article No. 57. https://malariajournal.biomedcentral.com/articles/10.1186/s12936-016-1673-z
[18]  Tan, E.M., St Sauver, J.L. and Sia, I.G. (2018) Impact of Pre-Travel Consultation on Clinical Management and Outcomes of Travelers’ Diarrhea: A Retrospective Cohort Study. Tropical Diseases, Travel Medicine and Vaccines, 4, Article16. https://pubmed.ncbi.nlm.nih.gov/30534413/
[19]  Bartoloni, A, and Zammarchi, L. (2012) Clinical Aspects of Uncomplicated and Severe Malar-ia. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3375727/
[20]  Greenberg, A.E. and Lobel, H.O. (1990) Mortality from Plasmodium falciparum Malaria in Travelers from the United States, 1959 to 1987. Annals of Internal Medicine, 113, 326-327. https://doi.org/10.7326/0003-4819-113-4-326
[21]  Song, H.H., O, S.O., Kim, S.H., Moon, S.H., Kim, J.B., Yoon, J.W., et al. (2003) Clinical Features of Plasmodium Vivax Malaria. The Korean Journal of Internal Medi-cine, 18, 220-224. https://doi.org/10.3904/kjim.2003.18.4.220
[22]  Raposo, C.C.B.S., Santos, J.B., Santos, G.M.C.D., et al. (2013) Plasmodium Vivax Malaria: Related Factors to Severity in the State of Maranhão, Brazil. Revista da Sociedade Brasileira de Medicina Tropical, 46, 67-72. https://doi.org/10.1590/0037-868212382013
[23]  Utama, M.S. and Merati, T.P. (2016) Management Malaria with Jaundice. Malaria Control & Elimination, 5, Article 147.
[24]  Anand, A.C. and Puri, P. (2005) Jaundice in Malaria. Journal of Gastroenterology and Hepatology, 20, 1322-1332. https://doi.org/10.1111/j.1440-1746.2005.03884.x
[25]  Zekar, L. and Sharman, T. (2023) Plasmodium falciparum Malaria. National Center for Bio-technology Information. https://www.ncbi.nlm.nih.gov/books/NBK555962/
[26]  Christen, D., Steffen, R. and Schlagenhauf, P. (2006) Deaths Caused by Malaria in Switzerland 1988-2002. The American Journal of Tropical Medicine and Hygiene, 75, 1188-1194. https://doi.org/10.4269/ajtmh.2006.75.1188
[27]  Bruneel, F., Hocqueloux, L., Alberti, C., Wolff, M., Chevret, S., Bédos, J., et al. (2003) The Clinical Spectrum of Severe Imported Falciparum Malaria in the Intensive Care Unit. American Journal of Respiratory and Critical Care Medicine, 167, 684-689. https://doi.org/10.1164/rccm.200206-631oc
[28]  Bruneel, F., Raffetin, A., Corne, P., et al. (2020) Management of Severe Imported Malaria in Adults. https://pubmed.ncbi.nlm.nih.gov/30266432/
[29]  Sinclair, D., Don-egan, S., Isba, R., et al. (2012) Artesunate versus Quinine for Treating Severe Malaria. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6532684/
[30]  World Health Organization (n.d.) Indicator Metadata Registry Details. Estimated Ma-laria Mortality Rate (per 100 000 Population). https://www.who.int/data/gho/indicator-metadata-registry/imr-details/16

Full-Text


Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133